The mouse as a useful model of tuberculosis

Tuberculosis

Volumn 83, Issue 1-3, 2003, Pages 112-115

  Orme, I M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CHEMOKINE; CYTOKINE; GLYCAN; LIPOPROTEIN; LYMPHOCYTE ANTIBODY; LYMPHOCYTE SURFACE MARKER; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

ANIMAL MODEL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DATA BASE; GENE DISRUPTION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INBRED STRAIN; INFECTION SENSITIVITY; KNOCKOUT GENE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TUBERCULOSIS;

EID: 0038520795     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(02)00069-0     Document Type: Conference Paper

References (29)

1. Modlin RL. Activation of Toll-like receptors by microbial lipoproteins: role in host defense. J Allergy Clin Immunol 2001;108:S104-6.
2. Takeshita F, Leifer CA, Gursel I, et al. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 2001;167:3555-8.
3. Bendelac A. CD1: presenting unusual antigens to unusual T lymphocytes. Science 1995;269:185-6.
4. Porcelli SA, Segelke BW, Sugita M, et al. The CD1 family of lipid antigen-presenting molecules. Immunol Today 1998;19:362-8.
5. Jullien D, Stenger S, Ernst WA, Modlin RL. CD1 presentation of microbial nonpeptide antigens to T cells. J Clin Invest 1997;99:2071-4.
6. Orme IM. The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis. J Immunol 1987;138:293-8.
7. Orme IM. Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection. J Immunol 1988;140:3589-93.
8. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995;84:423-32.
9. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, Bloom BR. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995;155:2515-24.
10. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993;178:2243-7.
11. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-54.
12. Cooper AM, Kipnis A, Turner J, Magram J, Ferrante J, Orme IM. Nice Lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 2002;168:1322-7.
13. Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992;89:12013-7.
14. Turner J, D'Souza CD, Pearl JE, et al. CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis. Am J Respir Cell Mol Biol 2001;24:203-9.
15. Gonzalez-Juarrero M, Turner OC, Turner J, Marietta P, Brooks JV, Orme IM. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect Immun 2001;69:1722-8.
16. Johnson CM, Cooper AM, Frank AA, Orme IM. Adequate expression of protective immunity in the absence of granuloma formation in Mycobacterium tuberculosis-infected mice with a disruption in the intracellular adhesion molecule 1 gene. Infect Immun 1998;66:1666-70.
17. Saunders BM, Frank AA, Orme IM. Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 1999;98:324-8.
18. Feng CG, Britton WJ, Palendira U, Groat NL, Briscoe H, Bean AG. Up-regulation of VCAM-1 and differential expansion of beta integrin-expressing T lymphocytes are associated with immunity to pulmonary Mycobacterium tuberculosis infection. J Immunol 2000;164:4853-60.
19. Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, Ernst JD. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2001;98:7958-63.
20. Russell DG. Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol 2001;2:569-77.
21. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001;19:93-129.
22. Medina E, North RJ. The Bcg gene (Nramp1) does not determine resistance of mice to virulent Mycobacterium tuberculosis. Ann NY Acad Sci 1996;797:257-9.
23. North RJ, Medina E. How important is Nramp1 in tuberculosis? Trends Microbiol 1998;6:441-3.
24. Turner J, Gonzalez-Juarrero M, Saunders BM, et al. Immunological basis for reactivation of tuberculosis in mice. Infect Immun 2001;69:3264-70.
25. Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tubercle Lung Dis 1997;78:57-66.
26. Orme IM. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol 1998;6:94-7.
27. Turner OC, Basaraba RJ, Orme IM. Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis. Infect Immun 2003;71:864-71.
28. Orme IM. Search for new drugs for treatment of tuberculosis. Antimicrob Agents Chemother 2001;45:1943-6.
29. Orme IM, McMurray DN, Belisle JT. Tuberculosis vaccine development: recent progress. Trends Microbiol 2001;9:115-8.